![]() |
市场调查报告书
商品编码
1916601
绿色溶剂和低VOC组合药物市场,全球预测至2032年:按溶剂类型、应用、最终用户和地区划分Green Solvents & Low-VOC Formulations Market Forecasts to 2032 - Global Analysis By Solvent Type (Bio-based Solvents, Water-based Solvents, Supercritical Fluids and Ionic Liquids & Deep Eutectic Solvents), Application, End User and By Geography |
||||||
根据 Stratistics MRC 的一项研究,全球绿色溶剂和低 VOC组合药物市场预计到 2025 年价值 22.9 亿美元,到 2032 年达到 40.6 亿美元,在预测期内以 8.5% 的复合年增长率增长。
随着企业将永续性和合规性置于优先地位,绿色溶剂和低VOC组合药物正逐渐成为首选。这些解决方案透过减少挥发性排放,有助于改善室内空气质量,并减轻对环境和职业健康的影响。生物基溶剂、水基系统和创新萃取介质等替代方案正逐步取代传统的溶剂化学方法。日益严格的环境法规和消费者对环保产品的需求不断增长,推动了这些替代方案在油漆涂料、药品、黏合剂和工业清洁剂等领域的应用。配方技术的持续创新使生产商能够在不牺牲安全性和效率的前提下,实现与传统溶剂相当的性能和耐久性。因此,绿色溶剂和低VOC组合药物正成为现代永续製造实践的核心。
根据美国环保署 (EPA) 的排放趋势数据,由于对油漆、涂料和工业溶剂的监管压力,美国人为 VOC排放已从 1990 年的 2,340 万吨下降到 2014 年的 1,290 万吨。
日益增长的健康和职业安全问题
人们日益关注员工健康和用户安全,这推动了绿色溶剂和低VOC组合药物的普及。传统的溶剂型系统通常会排放有害排放,引发呼吸系统疾病、过敏反应和慢性健康问题等风险。为了解决这些问题,越来越多的企业选择污染物排放量较低、毒性较小的溶剂替代品。更安全的配方有助于改善职场和密闭空间的空气质量,同时也有助于更安全的操作规范。此外,越来越多的企业采用低VOC产品,以符合安全准则并加强对员工的保护。这种对健康环保化学解决方案日益增长的需求正在推动市场扩张。
生产成本和原料成本高
不断上涨的製造成本和原材料成本正显着阻碍绿色溶剂和低VOC组合药物市场的成长。与传统化学原料相比,生物基原料的采购和加工成本往往较高。先进的生产技术和监管品质标准也推高了营运成本。这些成本压力推高了产品价格,常常阻碍了对成本敏感的产业采用这些产品。小规模生产商可能难以在保持盈利的同时承担这些成本。因此,儘管绿色溶剂解决方案具有环境效益,但其高昂的价格限制了其在价格敏感行业的接受度,从而减缓了市场渗透和大规模应用。
绿色化学的技术进步
绿色化学领域的持续创新为绿色溶剂和低VOC组合药物创造了成长机会。研究成果正在催生新的溶剂替代品和配方方法,这些方法在提高效率的同时还能减少排放。产品性能、耐久性和应用柔软性的提升,使绿色解决方案在与传统溶剂的竞争中更具优势。技术进步也支援客製化,以满足特定产业的需求,从而增强市场相关性。製造商、学术机构和技术提供者之间的合作进一步推动了产品开发。随着绿色化学的进步,成本障碍不断降低,扩大了商业性可行性,并为工业和消费领域的应用开闢了新的途径。
与传统溶剂系统和混合溶剂系统的竞争
传统溶剂系统和部分改质溶剂系统的存在对绿色溶剂和低VOC组合药物市场构成了激烈的竞争。传统溶剂产品因其价格实惠、性能稳定且基础设施成熟而仍然具有吸引力。混合型解决方案虽然能够适度降低VOC含量并维持较低的转型成本,但也与完全绿色的替代方案竞争。许多製造商倾向于选择这些过渡方案,以最大限度地减少营运影响和投资风险。这种趋势降低了转型为完全绿色配方的迫切性。来自传统溶剂系统和混合型系统的竞争,加上既定的行业惯例和对配方变更的抵触情绪,持续阻碍市场向永续溶剂解决方案转型的快速进展。
新冠疫情为绿色溶剂和低VOC组合药物市场带来了短期挑战和长期机会。严格的封锁措施和物流中断最初导致工业生产下降,限制了建筑和汽车製造等关键终端使用者产业的需求。供不应求和营运延误进一步限制了市场表现。同时,疫情加剧了人们对人类健康、卫生和环境安全的担忧。这种转变增加了医疗、卫生和製药业对低排放、无毒组合药物的需求。随着经济復苏,製造商更加重视永续和更安全的化学解决方案。因此,新冠疫情造成了暂时的挫折,但从长远来看,它也将推动绿色溶剂的广泛应用。
预计在预测期内,水性溶剂细分市场将占据最大的市场份额。
由于其用途广泛、价格实惠且易于实施,预计水性溶剂将在预测期内占据最大的市场份额。这些配方透过最大限度地减少排放(VOC) 的排放,在无需对製程进行重大更改的情况下,解决了环境和健康问题。它们在涂料、黏合剂、家用清洁剂和工业产品等各种应用中久经考验的可靠性,使其在众多行业中得到广泛认可。水性溶剂易于获取,并且可以顺利整合到现有生产系统中,这使其比新兴替代品更具优势。配方技术的进步提高了黏合强度、表面品质和干燥特性等性能指标。
预计在预测期内,製药业将实现最高的复合年增长率。
在对环境责任和人类安全的重视推动下,製药业预计将在预测期内实现最高成长率。製造商正加速从传统溶剂转向环保溶剂,以最大限度地降低毒性、提高职场安全并符合不断变化的监管标准。永续药物开发、清洁合成製程和高效溶剂回收利用等方面的努力进一步推动了这一趋势。全球药品产量的扩张和药品需求的成长也促进了该产业的成长。在监管审查日益严格和永续性期望不断提高的背景下,製药公司正在迅速采用环保型溶剂技术,预计该行业的成长速度将高于其他应用领域。
在预测期内,欧洲地区预计将保持最大的市场份额,这得益于严格的环境政策和成熟的产业生态系统。以排放和永续性为重点的监管要求正在推动传统溶剂被环保替代品广泛取代。涂料、化学和製药等行业的强大实力带来了稳定的需求。企业和终端用户日益增强的环保意识也在加速环保替代品的采用方面发挥关键作用。此外,该地区在永续化学解决方案方面拥有强大的研发能力和创新优势。积极的监管措施、产业的充分准备以及以永续性为中心的策略相结合,将使欧洲能够继续保持其在全球绿色溶剂和低VOC组合药物市场中的最大份额。
预计亚太地区在预测期内将实现最高的复合年增长率,这主要得益于强劲的经济和工业发展。快速的都市化和不断扩张的产业部门正在推动对环保溶剂解决方案的需求。监管机构日益严格的排放限制迫使製造商采用更环保的替代方案。新兴经济体的崛起、化工製造业投资的增加以及跨国公司业务的拓展,都在推动市场扩张。此外,消费者对健康、安全和永续性的日益关注也推动了对低排放产品的需求。随着这些趋势的持续发展,预计亚太地区将成为全球成长最快的地区。
According to Stratistics MRC, the Global Green Solvents & Low-VOC Formulations Market is accounted for $2.29 billion in 2025 and is expected to reach $4.06 billion by 2032 growing at a CAGR of 8.5% during the forecast period. Green solvents and low-VOC formulations are emerging as preferred choices as companies prioritize sustainability and regulatory compliance. By lowering volatile emissions, these solutions help enhance indoor air quality and reduce environmental and occupational health impacts. Alternatives such as bio-derived solvents, water-based systems, and innovative extraction media are steadily replacing traditional solvent chemistries. Stricter environmental regulations and growing customer demand for eco-friendly products are driving their use in sectors including paints, coatings, pharmaceuticals, adhesives, and industrial cleaners. Ongoing innovations in formulation technologies allow producers to achieve comparable performance and durability without compromising safety or efficiency. Consequently, green solvents and low-VOC formulations are becoming central to modern, sustainable manufacturing practices.
According to the U.S. EPA emissions trends data, data shows that anthropogenic VOC emissions in the U.S. declined from 23.4 million tons in 1990 to 12.9 million tons in 2014, largely due to regulatory pressure on paints, coatings, and industrial solvents.
Growing health and occupational safety concerns
Rising concerns over employee health and user safety are fueling the shift toward green solvents and low-VOC formulations. Conventional solvent systems are often linked to harmful emissions that pose risks such as breathing problems, allergic reactions, and chronic health effects. To address these issues, companies are increasingly choosing solvent alternatives that release fewer pollutants and are less toxic. Safer formulations help improve air quality in workplaces and enclosed spaces while supporting safer handling practices. Organizations are also motivated to adopt low-VOC products to comply with safety guidelines and enhance workforce protection. This growing emphasis on health-conscious chemical solutions is strengthening market expansion.
High production and raw material costs
Elevated manufacturing and material expenses significantly hinder the growth of the green solvents and low-VOC formulations market. Bio-derived feedstocks typically involve higher sourcing and processing costs compared to traditional chemical raw materials. Advanced production methods and compliance-driven quality standards also contribute to increased operational expenditures. These cost pressures often result in higher product prices, discouraging adoption among cost-conscious industries. Smaller producers may struggle to absorb these expenses while maintaining profitability. Consequently, despite environmental advantages, the premium pricing of green solvent solutions limits their acceptance in price-sensitive sectors, slowing market penetration and large-scale implementation.
Technological advancements in green chemistry
Ongoing innovation in green chemistry presents major opportunities for the growth of green solvents and low-VOC formulations. Research efforts are yielding new solvent alternatives and formulation methods that improve effectiveness while lowering emissions. Enhanced product performance, durability, and application flexibility are making green solutions more competitive with traditional solvents. Technological progress also supports customization for industry-specific requirements, increasing market relevance. Partnerships among manufacturers, academic institutions, and technology providers are further driving product development. As green chemistry advances, it reduces cost barriers and expands commercial viability, opening new avenues for adoption across industrial and consumer-focused applications.
Competition from conventional and hybrid solvent systems
The presence of conventional and partially modified solvent systems presents a strong competitive threat to the green solvents and low-VOC formulations market. Traditional solvent products remain attractive due to their affordability, consistent performance, and mature infrastructure. Hybrid solutions that offer moderate VOC reductions at lower transition costs also compete with fully green alternatives. Many manufacturers prefer these interim options to minimize operational disruption and investment risk. This preference reduces urgency for adopting entirely green formulations. Combined with established industry practices and resistance to reformulation, competition from conventional and hybrid systems continues to restrain rapid market transformation toward sustainable solvent solutions.
The outbreak of COVID-19 created short-term challenges and long-term opportunities for the green solvents and low-VOC formulations market. Strict lockdown measures and logistical interruptions initially reduced industrial output and limited demand from key end-use industries such as construction and automotive manufacturing. Supply shortages and operational delays further constrained market performance. Conversely, the pandemic heightened focus on human health, hygiene, and environmental safety. This shift increased demand for low-emission, non-toxic formulations in healthcare, sanitation, and pharmaceutical products. As economies recovered, manufacturers placed greater emphasis on sustainable and safer chemical solutions. Consequently, while COVID-19 caused temporary setbacks, it ultimately supported stronger adoption of green solvents over time.
The water-based solvents segment is expected to be the largest during the forecast period
The water-based solvents segment is expected to account for the largest market share during the forecast period because of their versatility, affordability, and ease of implementation. By minimizing VOC emissions, these formulations address environmental and health concerns without requiring major process changes. Their proven reliability across applications such as coatings, adhesives, household cleaners, and industrial products supports extensive industry acceptance. Water-based solvents are readily available and integrate smoothly with established production systems, giving them an advantage over emerging alternatives. Advancements in formulation science have improved performance attributes such as adhesion strength, finish quality, and drying behavior.
The pharmaceuticals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pharmaceuticals segment is predicted to witness the highest growth rate, driven by the sector's strong focus on environmental responsibility and human safety. Manufacturers are increasingly replacing conventional solvents with greener alternatives to minimize toxicity, enhance workplace safety, and align with evolving regulatory standards. The push toward sustainable drug development, cleaner synthesis processes, and efficient solvent reuse is further supporting adoption. Expanding pharmaceutical production worldwide and rising demand for medicines is also contributing to growth. As regulatory scrutiny and sustainability expectations continue to rise, pharmaceutical companies are rapidly integrating green solvent technologies, positioning this segment for higher growth than other application areas.
During the forecast period, the Europe region is expected to hold the largest market share, supported by rigorous environmental policies and a mature industrial ecosystem. Regulatory mandates focused on emission reduction and sustainability has driven widespread replacement of conventional solvents with eco-friendly alternatives. Strong presence of industries such as coatings, chemicals, and pharmaceuticals contributes to consistent demand. Environmental consciousness among businesses and end users also plays a crucial role in accelerating adoption. Furthermore, the region benefits from robust research capabilities and innovation in sustainable chemistry solutions. Together, proactive regulations, industrial readiness, and sustainability-driven strategies enable Europe to maintain the largest share in the global green solvents and low-VOC formulations market.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, supported by strong economic and industrial development. Rapid urbanization and expanding industrial sectors are increasing the need for environmentally responsible solvent solutions. Regulatory bodies are introducing stricter guidelines on emissions, prompting manufacturers to adopt greener alternatives. The presence of emerging economies, rising investments in chemical manufacturing and growing participation of multinational companies accelerate market expansion. Furthermore, increasing consumer focus on health, safety, and sustainability is boosting demand for low-emission products. As these trends continue, Asia-Pacific is set to achieve the highest growth rate globally.
Key players in the market
Some of the key players in Green Solvents & Low-VOC Formulations Market include Dow Inc., BASF SE, Evonik Industries AG, Ashland Global Holdings Inc., Clariant AG, Corbion N.V., Archer Daniels Midland Company, Cargill, Incorporated, Solvay, Stepan Company, Vertec BioSolvents, LyondellBasell Industries N.V., Huntsman Corporation, Eastman Chemical Company and AkzoNobel.
In October 2025, Dow and MEGlobal have finalized an agreement for Dow to supply an additional equivalent to 100 KTA of ethylene from its Gulf Coast operations. The ethylene will serve as a key feedstock for MEGlobal's ethylene glycol (EG) manufacturing facility co-located at Dow's and MEGlobal's Oyster Creek site.
In October 2025, BASF and IFF Launch Strategic Partnership for Next-Gen Enzyme and Polymer Innovations. The aim of the collaboration between BASF and IFF is to accelerate the development of IFF's Designed Enzymatic Biomaterials technology platform and to develop next-generation enzyme technologies for applications in detergents, industrial cleaning and personal care products.
In March 2025, Evonik has entered into an exclusive agreement with the Cleveland-based Sea-Land Chemical Company for the distribution of its cleaning solutions in the U.S. The agreement builds on a long-standing relationship with the distributor and expands the reach of Evonik's cleaning solutions to the entire U.S. region.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.